Samantha J Thompson - Publications
Affiliations: | University of Alabama, Birmingham, Birmingham, AL, United States | ||
2018- | Neuroscience | Baylor College of Medicine, Houston, TX |
Year | Citation | Score | |||
---|---|---|---|---|---|
2023 | Roth JR, Rush T, Thompson SJ, Aldaher AR, Dunn TB, Mesina JS, Cochran JN, Boyle NR, Dean HB, Yang Z, Pathak V, Ruiz P, Wu M, Day JJ, Bostwick JR, et al. Development of small-molecule Tau-SH3 interaction inhibitors that prevent amyloid-β toxicity and network hyperexcitability. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 21: e00291. PMID 38241154 DOI: 10.1016/j.neurot.2023.10.001 | 0.462 | |||
2022 | Aloi MS, Thompson SJ, Quartapella N, Noebels JL. Loss of functional System x-c uncouples aberrant postnatal neurogenesis from epileptogenesis in the hippocampus of Kcna1-KO mice. Cell Reports. 41: 111696. PMID 36417872 DOI: 10.1016/j.celrep.2022.111696 | 0.4 | |||
2021 | Massey CA, Thompson SJ, Ostrom RW, Drabek J, Sveinsson OA, Tomson T, Haas EA, Mena OJ, Goldman AM, Noebels JL. X-linked serotonin 2C receptor is associated with a non-canonical pathway for sudden unexpected death in epilepsy. Brain Communications. 3: fcab149. PMID 34396109 DOI: 10.1093/braincomms/fcab149 | 0.401 | |||
2019 | Rush T, Roth JR, Thompson SJ, Aldaher AR, Cochran JN, Roberson ED. A peptide inhibitor of Tau-SH3 interactions ameliorates amyloid-β toxicity. Neurobiology of Disease. 104668. PMID 31698056 DOI: 10.1016/J.Nbd.2019.104668 | 0.44 | |||
Show low-probability matches. |